<DOC>
	<DOCNO>NCT00643227</DOCNO>
	<brief_summary>The study perform confirm single , 2.0 g oral dose azithromycin sustain release ( SR ) least effective 7 day clarithromycin extend release ( ER ) , 1.0 g mouth daily , use treat adult mild moderate community acquire pneumonia ( CAP ) , treatment safe .</brief_summary>
	<brief_title>A Multicenter , Randomized , Double-Blind , Double-Dummy Trial Azithromycin SR Compared With Clarithromycin Extended Release Treatment Pneumonia Adult Patients</brief_title>
	<detailed_description />
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Clarithromycin</mesh_term>
	<criteria>Outpatients diagnosis pneumonia , demonstrate productive cough least 2 follow sign symptom : rale and/or evidence pulmonary consolidation ; dyspnea tachypnea ; elevate body temperature ; elevate total peripheral white blood cell count ( WBC &gt; 10,000/mm3 ) great 15 % immature neutrophils include . Patients chest radiograph demonstrate evidence new infiltrate consolidation , Modified Fine Risk score â‰¤ 70 ( Fine Class I II ) . Patients treat systemic antibiotic great 1 dose 1 combination dose ( cephalosporin macrolide ) within previous 7 day , likelihood receive systemic antibiotic participation study ; hospitalize previous 14 day infection acquire hospital , resident longterm care facility exclude .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2008</verification_date>
</DOC>